Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the NHS plans to expand the use of System One computer software.
Answered by Andrew Stephenson
The procurement of electronic patient record systems is conducted at an integrated care board or trust level, following specific procurement criteria. Consequently, decisions regarding software adoption and expansion will be made by National Health Service trusts. All procurement activity for patient record systems is conducted in compliance with regulations, which means that the outcome of future procurements cannot be known at this point.
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department has undertaken an impact assessment on the potential impact of closing maternity services at the Royal Free Hospital.
Answered by Maria Caulfield
The Department has not undertaken such an assessment. The North Central London Integrated Care Board has conducted an impact assessment on the proposals as part of its consultation on proposed changes to maternity, neonatal, and children’s surgical services in North Central London, which is due to close on 17 March 2024. This impact assessment is available at the following link:
https://nclhealthandcare.org.uk/wp-content/uploads/2023/12/ALT-TEXT_Maternity-Neonates-IIA-1.pdf
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of using radio wave imaging technology, including the MARIA system, to screen people for breast cancer.
Answered by Helen Whately - Shadow Secretary of State for Work and Pensions
The UK National Screening Committee (UK NSC) has looked at the evidence for offering extra breast screening tests, including breast density, in addition to standard mammography.
So far, the committee has found that the evidence for such technologies, although promising, is not yet strong enough for it to recommend that they be introduced into the NHS Breast Screening Programme. It has not looked specifically at the MARIA system.
The UK NSC continually monitors progress and remains interested in significant evidence that will allow improvements in breast screening. Any member of the public can submit a proposal to modify a screening programme during the UK NSC’s annual call.
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the value for money of purchases of PPE from Unispace Global Ltd; and if he will make a statement.
Answered by Edward Argar
Contracts between the Department and Unispace Global Ltd were novated to Unispace Health Products LLP in December 2020, which is now known as Sante Global LLP. We are unable to provide the information requested as it is commercially sensitive. However, the Department has established a contract dissolution team to maximise the value obtained from contracts for personal protective equipment.
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, from which companies Unispace Global Ltd purchased personal protective equipment in (a) 2020 and (b) 2021.
Answered by Edward Argar
We are unable to provide the information requested as it is commercially sensitive.
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 April 2022 to Question 117746 on Unispace Global: Protective Clothing, what proportion of the supplies purchased by the Government under the £603 million Unispace Global Ltd contract (a) were received and (b) met safety standards.
Answered by Edward Argar
We are unable to provide the information requested as it is commercially sensitive.
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to respond to Question 117746 on Unispace Global: Protective Clothing tabled by the hon. Member for Brent Central on 3 March 2022.
Answered by Edward Argar
I refer the hon Member to the answer to Question 117746.
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department paid £600 million to Unispace Global Ltd for the purchase of personal protective equipment in 2020; and if he will provide a breakdown of the supplies purchased under contracts awarded by the Department to Unispace Global Ltd.
Answered by Edward Argar
The Department paid £603 million to Unispace Global Ltd for the purchase of personal protective equipment in 2020 and the remaining amount in 2021.
The supplies purchased under contracts awarded by Unispace Global Ltd by the Department were gloves and face masks. We are unable to provide a further breakdown of the supplies as this information is commercially sensitive.
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people have received the covid-19 vaccinations at walk-in and pop up clinics in London; and how many and what proportion of those people (i) did not have a NHS number and (ii) were not registered with a GP.
Answered by Maggie Throup
The information requested is not held centrally.
Asked by: Dawn Butler (Labour - Brent East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people were on the (a) 31 day cancer Patient Tracking List and (b) 62 day cancer Patient Tracking List as of 22 March 2022; and how many people were taken off each of those lists in each of the last 12 months.
Answered by Maria Caulfield
This information is not available in the format requested. The cancer Patient Tracking List (PTL) is a monitoring tool used by hospitals for management of their waiting lists and is not centrally validated. A patient is removed from the 31 day or 62 day pathway and PTL monitoring when:
- the organisation communicates to the patient that a cancer diagnosis has been excluded;
- a first definitive treatment has been completed or permitted enabling treatment;
- a patient declines treatment;
- a patient chooses to receive treatment privately; and
- death occurs before treatment.